0001140361-16-066278.txt : 20160519 0001140361-16-066278.hdr.sgml : 20160519 20160519160534 ACCESSION NUMBER: 0001140361-16-066278 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160519 DATE AS OF CHANGE: 20160519 EFFECTIVENESS DATE: 20160519 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PIPER THERAPEUTICS INC. CENTRAL INDEX KEY: 0001654487 IRS NUMBER: 474534728 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-263541 FILM NUMBER: 161663231 BUSINESS ADDRESS: STREET 1: ONE BROADWAY, 14TH FL CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-527-1572 MAIL ADDRESS: STREET 1: ONE BROADWAY, 14TH FL CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0707 D LIVE 0001654487 PIPER THERAPEUTICS INC. ONE BROADWAY, 14TH FL CAMBRIDGE MA MASSACHUSETTS 02142 617-527-1572 DELAWARE None None Corporation true 2015 Russell J. Wilcox One Broadway, 14th Floor Canbridge MA MASSACHUSETTS 02142 Executive Officer Director Mr. Wilcox is the President and Chief Executive Officer of the Issuer. Lois Smith One Broadway, 14th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Ms. Smith is the Secretary of the Issuer. Richard Lim c/o Omega Fund Management LLC 185 Dartmouth Street, Suite 502 Boston MA MASSACHUSETTS 02116 Director Pharmaceuticals Decline to Disclose 06b false 2016-05-06 false true true Series Seed Preferred Stock false 0 1300000 1295013 4987 false 5 0 0 0 false PIPER THERAPEUTICS INC. /s/ Russell J. Wilcox Russell J. Wilcox President and CEO of the Issuer 2016-05-19